ACRV
#3966
Acrivon Therapeutics, Inc. - Common Stock
2.1 2 USD
+0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.42%
Variación mensual
+39.47%
Variación en los últimos 6 meses
+43.24%
Cambio anual
+59.40%
Cierres anteriores
2.0 7
Open
2.1 0
Mínimo
2.1 0
Máximo
2.1 2
Volumen
19
Financials
- Market Capitalization 90.85 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3943 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.15 USD | +1.44% | -4.19% | +8.67% | -37.97% | 91.85 M USD | ||
| 3957 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.37 USD | +2.48% | +7.40% | +2.87% | -10.80% | 92.25 M USD | ||
| 3968 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.47 USD | -1.34% | -6.37% | -5.16% | -74.17% | 88.68 M USD | ||
| 3971 |  ICCC ImmuCell Corporation - Common Stock | 9.94 USD | +0.20% | -0.80% | -12.27% | +52.45% | 90.28 M USD |